Intrexon | XON - Bienes





Bienes Cambio Fecha
Agenus USD 172.69M 13.76M 2026-06
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Amgen USD 95.64B 3.14B 2026-06
Anika Therapeutics USD 183.47M 4.09M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Heron Therapeutics USD 252.26M 6.05M 2026-06
Incyte USD 7.87B 533.53M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Ligand Pharmaceuticals USD 2.19B 653.77M 2026-06
MacroGenics USD 345.41M 127.54M 2026-06
MannKind USD 732.3M 12.1M 2026-06
Merck USD 129.8B 1.12B 2026-06
Novartis USD 122.03B 3.5B 2026-06
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Veracyte USD 1.49B 49.97M 2026-06
Xencor USD 724.96M 11.89M 2026-06